Monday, 28 September 2026Updated 6m ago
← Top stories
Expansion▲ Bullish for Epigral

Epigral targets ₹5,000 crore revenue by FY31 on capacity expansions

3 sources · first seen 15:29 27 Sept · updated 16:47 27 Sept

The brief

Written from 3 reports · check the source before you trade
  • Epigral expects revenue of ₹2,900 crore this fiscal year
  • Its FY31 target is ₹5,000 crore, driven by CPVC Resin and ECH scale-ups
  • Capacity expansion and revenue targets put Epigral investors in focus; execution will determine growth

Tags on this story

Pick a tag to see all its stories
Epigral₹1,060.60 · 1 todaySpecialty chemicals1 todayChemicals2 today

Read the reports

3 reports · earliest 15:29
Business StandardCapacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD15:29Business LineCapacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD Maulik Patel16:08Economic TimesCapacity scale-ups to drive Epigral's Rs 5,000 crore target by FY31: CMD Maulik Patel16:47